"Hypercalcemia" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Abnormally high level of calcium in the blood.
Descriptor ID |
D006934
|
MeSH Number(s) |
C18.452.174.451 C18.452.950.340
|
Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Hypercalcemia".
Below are MeSH descriptors whose meaning is more specific than "Hypercalcemia".
This graph shows the total number of publications written about "Hypercalcemia" by people in this website by year, and whether "Hypercalcemia" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
1994 | 1 | 0 | 1 |
1995 | 1 | 0 | 1 |
1996 | 1 | 0 | 1 |
2001 | 1 | 0 | 1 |
2003 | 0 | 1 | 1 |
2004 | 2 | 0 | 2 |
2005 | 2 | 1 | 3 |
2006 | 1 | 0 | 1 |
2007 | 1 | 0 | 1 |
2008 | 1 | 1 | 2 |
2010 | 1 | 1 | 2 |
2013 | 1 | 1 | 2 |
2014 | 0 | 1 | 1 |
2017 | 0 | 1 | 1 |
2018 | 1 | 0 | 1 |
2021 | 1 | 1 | 2 |
2023 | 2 | 0 | 2 |
To return to the timeline,
click here.
Below are the most recent publications written about "Hypercalcemia" by people in Profiles.
-
Severe Hypercalcemia and Lytic Lesions in a 10-Year-Old Female. Clin Pediatr (Phila). 2024 Jun; 63(6):859-862.
-
Endocrine Society Hypercalcemia of Malignancy Guidelines. JAMA Oncol. 2023 03 01; 9(3):430-431.
-
Primary hyperparathyroidism: Disease of diverse genetic, symptomatic, and biochemical phenotypes. Head Neck. 2021 12; 43(12):3996-4009.
-
Evaluation of Frequency of Administration of Intravenous Bisphosphonate and Recurrent Skeletal-Related Events in Patients With Multiple Myeloma. JAMA Netw Open. 2021 07 01; 4(7):e2118410.
-
Degree of hypercalcemia correlates with parathyroidectomy but not with symptoms. Am J Surg. 2019 03; 217(3):437-440.
-
Hypoparathyroidism. Nat Rev Dis Primers. 2017 08 31; 3:17055.
-
A randomized multicenter trial of paricalcitol versus calcitriol for secondary hyperparathyroidism in stages 3-4 CKD. Clin J Am Soc Nephrol. 2014 Sep 05; 9(9):1620-6.
-
1,25(OH)2D3-enhanced hypercalciuria in genetic hypercalciuric stone-forming rats fed a low-calcium diet. Am J Physiol Renal Physiol. 2013 Oct 15; 305(8):F1132-8.
-
Characterization of the effect of chronic administration of a calcium-sensing receptor antagonist, ronacaleret, on renal calcium excretion and serum calcium in postmenopausal women. Bone. 2013 Sep; 56(1):154-62.
-
Increased biological response to 1,25(OH)(2)D(3) in genetic hypercalciuric stone-forming rats. Am J Physiol Renal Physiol. 2013 Mar 15; 304(6):F718-26.